Cite
APA Citation
Caiazza, F., Murray, A., Madden, S. F., Synnott, N. C., Ryan, E. J., O'Donovan, N., Crown, J., & Duffy, M. J. (2016). preclinical evaluation of the AR inhibitor enzalutamide in triple-negative breast cancer cells. Endocrine-related cancer, 23(4), 323–334. http://access.bl.uk/ark:/81055/vdc_100081363502.0x000030